RMTG · Regenerative Medical Technology Group Inc. · Insider Trading
$0.04
+0.00 (+6.38%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The financial statements have been prepared assuming the Company will continue as a going concern. The Company has incurred losses since inception, resulting in an accumulated deficit of approximately $79,484,265 and a working capital deficit of $40,328,417 as of June 30, 2026, and future losses are anticipated. These factors, among others, raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 19, 2026
Market Cap
$548,184
Shares
13.74M
Volume · Oct 20
1500
Avg daily vol (3M)
64.98K
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2021-08-18 | Christensen David Eugene |
CHIEF EXECUTIVE OFFICER |
Award↑
Filing footnotes — Series DD Preferred Stock (Direct)
These securities were issued under the Reporting Person's employment agreement as compensation. |
Series DD Preferred Stock
|
448 |
Legend
Buy — open-market purchase
Sell — open-market sale
↑ Shares acquired
↓ Shares disposed (gift, conversion, tax…)
Showing 1–1 of 1 transactions